| Drug Name |
Ceftibuten dihydrate |
| Drug ID |
BADD_D00401 |
| Description |
Ceftibuten is a third-generation cephalosporin antibiotic that is orally-administered. It is typically used to treat acute bacterial exacerbations of chronic bronchitis (ABECB), acute bacterial otitis media, pharyngitis, and tonsilitis. |
| Indications and Usage |
Indicated for the treatment of acute bacterial exacerbations of chronic bronchitis (ABECB), acute bacterial otitis media, pharyngitis, and tonsilitis. |
| Marketing Status |
approved; investigational |
| ATC Code |
J01DD14 |
| DrugBank ID |
DB01415
|
| KEGG ID |
D02121
|
| MeSH ID |
D000077722
|
| PubChem ID |
5282241
|
| TTD Drug ID |
D05JDR
|
| NDC Product Code |
Not Available |
| UNII |
62F4443RWP
|
| Synonyms |
Ceftibuten | 7-(2-(2-amino-4-thiazolyl)-4-carboxy-2-butenoylamino)-3-cephem-4-carboxylic acid | 7432 S | 7432-S | SCH 39720 | SCH39720 | SCH-39720 | Cedax |
